We are live on ! Find out more
PODD icon

Insulet

682 hedge funds and large institutions have $18.4B invested in Insulet in 2024 Q4 according to their latest regulatory filings, with 126 funds opening new positions, 248 increasing their positions, 225 reducing their positions, and 54 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more funds holding in top 10

Funds holding in top 10: 25 (+3)

133% more first-time investments, than exits

New positions opened: 126 | Existing positions closed: 54

12% more capital invested

Capital invested by funds: $16.5B → $18.4B (+$1.93B)

10% more repeat investments, than reductions

Existing positions increased: 248 | Existing positions reduced: 225

10% more funds holding

Funds holding: 622682 (+60)

0.56% less ownership

Funds ownership: 101.1%100.53% (-0.56%)

31% less call options, than puts

Call options by funds: $123M | Put options by funds: $177M

Holders
682
Holders Change
+60
Holders Change %
+9.65%
% of All Funds
8.98%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.07%
New
126
Increased
248
Reduced
225
Closed
54
Calls
$123M
Puts
$177M
Net Calls
-$54.3M
Net Calls Change
+$11.6M
Name Holding Trade Value Shares
Change
Change in
Stake
AAM
51
AMI Asset Management
California
$46.3M -$858K -3,405 -2%
CC
52
Chicago Capital
Illinois
$44.1M +$86.6K +344 +0.2%
Capital World Investors
53
Capital World Investors
California
$43.9M
HSBC Holdings
54
HSBC Holdings
United Kingdom
$43.7M +$2.06M +8,171 +5%
Sumitomo Mitsui Trust Group
55
Sumitomo Mitsui Trust Group
Japan
$41.7M +$845K +3,354 +2%
Renaissance Technologies
56
Renaissance Technologies
New York
$41.5M +$12.6M +49,900 +46%
Jennison Associates
57
Jennison Associates
New York
$41.3M +$7.15M +28,375 +22%
Millennium Management
58
Millennium Management
New York
$41.3M -$3.67M -14,566 -8%
Adage Capital Partners
59
Adage Capital Partners
Massachusetts
$40.6M -$25.6M -101,820 -40%
Wells Fargo
60
Wells Fargo
California
$40.3M -$2.1M -8,358 -5%
ITP
61
Iron Triangle Partners
Connecticut
$40.2M +$11.1M +44,014 +40%
BIAS
62
Beacon Investment Advisory Services
New Jersey
$39.4M -$2.97M -11,804 -7%
CWG
63
C WorldWide Group
Denmark
$38.6M -$5.04M -20,000 -12%
Nomura Asset Management
64
Nomura Asset Management
Japan
$37.9M -$2.07M -8,217 -5%
First Trust Advisors
65
First Trust Advisors
Illinois
$37.8M +$15.2M +60,187 +71%
RhumbLine Advisers
66
RhumbLine Advisers
Massachusetts
$37.3M -$565K -2,242 -2%
UBS Group
67
UBS Group
Switzerland
$37.2M +$6.41M +25,465 +22%
Barclays
68
Barclays
United Kingdom
$34.5M -$2.82M -11,197 -8%
BNP Paribas Financial Markets
69
BNP Paribas Financial Markets
France
$33.5M +$12.9M +51,248 +66%
AAMU
70
AEGON Asset Management (UK)
United Kingdom
$33.5M -$1.81M -7,189 -5%
PHP
71
Parkman Healthcare Partners
Connecticut
$32.8M -$8.54M -33,928 -21%
Comerica Bank
72
Comerica Bank
Texas
$31.9M -$3.15M -12,498 -9%
National Pension Service
73
National Pension Service
South Korea
$31.2M -$2.28M -9,048 -7%
HRCM
74
Hawk Ridge Capital Management
California
$30.3M +$29.3M +116,210 New
Universal-Beteiligungs- und Servicegesellschaft
75
Universal-Beteiligungs- und Servicegesellschaft
Germany
$30M +$28.9M +114,883 New

PODD Hedge Fund Activity: Q4 2024 in Review

682 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Insulet (PODD) for Q4 2024, worth a combined $18.4B — up 12% from $16.5B a quarter earlier.

Buyers outnumbered sellers: 126 funds opened new PODD positions and 54 closed out — a net gain of 72 holders — while 248 added to existing stakes and 225 trimmed.

The largest buyer was BlackRock, adding an estimated $70.3M. The largest seller was Goldman Sachs, cutting an estimated $83M.

  • 682 institutional investors held Insulet (PODD) as of Q4 2024, up from 622 in Q3 2024.
  • Funds reported $18.4B of Insulet stock for Q4 2024, up 12% quarter-over-quarter.
  • 126 funds opened new Insulet positions in Q4 2024 and 54 closed out, a net change of +72 holders.
  • The largest Insulet buyer in Q4 2024 was BlackRock, an estimated $70.3M added.
  • The largest Insulet seller in Q4 2024 was Goldman Sachs, an estimated $83M sold.

Based on aggregated 13F filings for Q4 2024.